Drug Type Monoclonal antibody |
Synonyms Anti-MIF monoclonal antibody, Immunoglobulin g1-kappa, anti-(homo sapiens mif (macrophage migration inhibitory factor, glycosylation-inhibiting factor, glif, gif)), homo sapiens monoclonal antibody, BAX-069 + [1] |
Target |
Action inhibitors, modulators |
Mechanism MIF inhibitors(Macrophage migration inhibitory factor inhibitors), Immunomodulators |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Malignant ascites | Phase 2 | United States | 02 Nov 2015 | |
Refractory Ovarian Carcinoma | Phase 2 | United States | 02 Nov 2015 | |
Metastatic Colorectal Carcinoma | Phase 2 | United States | 15 Jun 2015 | |
Ascites | Phase 2 | - | - | |
Colorectal Cancer | Phase 2 | - | - | |
Lupus Nephritis | Phase 1 | United States | 28 Nov 2011 | |
Lupus Nephritis | Phase 1 | Australia | 28 Nov 2011 | |
Lupus Nephritis | Phase 1 | Canada | 28 Nov 2011 | |
Lupus Nephritis | Phase 1 | Mexico | 28 Nov 2011 | |
Lupus Nephritis | Phase 1 | New Zealand | 28 Nov 2011 |
Phase 1/2 | 2 | (Single-Route Arm) | huynmpxhpa = cwahawqhuw uacsrwfemt (qqmwjsfotm, oolqfbgopc - vfwmtoafbn) View more | - | 15 Jun 2017 | ||
(Double-Route Arm) | huynmpxhpa = ysdztsckpz uacsrwfemt (qqmwjsfotm, ckkvykwbdc - klstkaajah) View more |